Waleed Al Muhairi

Ellipses Pharma is an international drug development company, focused exclusively on the advancement of innovative cancer treatments through the clinic. New treatments for cancer are not progressing fast enough. Ellipses is dedicated to making a difference. Headquartered in London, Ellipses is run by a world class leadership team, overseeing a rapidly growing pipeline of high quality clinical oncology opportunities. Supported by privileged partnerships with leading academic institutions, research bodies, universities, Big Pharma and extensive professional networks, Ellipses Pharma aims to be the most direct route from the research laboratory to patients for cancer treatments. Clinical trials are the route to developing more cancer treatments. All too often they have become overly complex and expensive, slowing down the progress of new discoveries and new treatments for patients. We streamline the clinical trials process that so often inhibits the progress of new potential drugs with one overarching objective - making more treatments available to patients. Ellipses provides a permanent source of capital for the development of cancer assets via a scalable business model, and is able to conduct multiple oncology clinical trials in parallel. Supported by our Scientific Affairs Group which comprises many of the worlds leading oncologists, Ellipses is taking a new, ambitious approach to significantly impact the cancer drug development market.

FAB, the UAE’s largest bank and one of the world’s largest financial institutions offers an extensive range of tailor-made solutions, and products and services, to provide a customised banking experience. Through its strategic offerings, it looks to meet the banking needs of customers across the world via its market-leading Corporate and Investment Banking and Personal Banking franchises. Headquartered in Abu Dhabi, in Khalifa Business Park, the bank’s international network spans over 19 countries, across the world, providing the global relationships, expertise and financial strength to support local, regional and international businesses seeking to do business at home and abroad. In line with its commitment to put customers first, to Grow Stronger, FAB will continually invest in people and technology to create the most customer-friendly banking experience and will support the growth ambitions of its stakeholders across the global network in which the bank operates. To empower its customers and clients to Grow Stronger, FAB is initiating a powerful movement, which goes beyond banking. The Grow Stronger movement represents the bank’s promise to support its stakeholders’ goals and growth ambitions, providing ideas, tools and expertise to help them become stronger, today and in the future. Through a strong, diversified balance sheet, leading efficiency and a solid corporate governance structure in place, FAB is set to drive growth forward. Privacy Policy https://bit.ly/3iORn8G

Home to Tech Startups from all sectors looking to disrupt industries, setup and grow their businesses from Abu Dhabi to the world. 🌍 #Hub71

Abu Dhabi Global Market (ADGM), an international financial centre (IFC) located in the capital city of the United Arab Emirates, opened for business on 21 October 2015. Established by UAE Federal Decree as a broad-based financial centre, ADGM augments Abu Dhabi’s position as a global hub for business and finance and serves as a strategic link between the growing economies of the Middle East, Africa and South Asia and the rest of the world. ADGM’s strategy is anchored by Abu Dhabi’s key strengths including private banking, wealth management, asset management and financial innovation. Comprising three independent authorities: ADGM Courts, the Financial Services Regulatory Authority and the Registration Authority, ADGM as IFC governs the Al Maryah Island which is a designated financial free zone. It enables registered financial institutions, companies and entities to operate, innovate and succeed within an international regulatory framework based on Common Law. Since its inception, ADGM has been awarded the “Financial Centre of the Year (MENA)” for two consecutive years for its initiatives and contributions to the financial and capital markets industry in the region.* * Source: The Global Investor Middle East and North Africa (MENA) Awards For questions or enquiries, please email: info@adgm.com Follow us on Twitter @adglobalmarket

Emirates Investment Authority (EIA) is the only Sovereign Wealth Fund of the Federal Government of the United Arab Emirates. Established in 2007, the EIA has actively sought unique investment opportunities locally, regionally and internationally, focusing on investing in asset classes that will help strengthen and diversify the UAE economy. Its primary directive is to manage the sovereign wealth of the UAE by investing in a diversified portfolio of assets in key economic sectors and industries with the aim of delivering sustained financial gains for the UAE.

كان الهدف من تأسيسنا هو إنشاء مشاريع عقارية ذات مستوى عالمي لمدينة أبوظبي، مع توفير محفظة استثمارية مستقرة ومربحة لجميع المستثمرين لدينا نحن ملتزمون بتحقيق معايير جديدة للابتكار والتميز والقيمة في التصميم المدني والتنمية المستدامة. أولويتنا هي الفائدة الفورية والمستقبلية لأبو ظبي والمقيمين فيها قمنا بتطوير مشاريع مميزة ومبتكرة كالمبنى HQ للدار المعروف عالميا والواقع في شاطئ الراحة، وأبراج البوابة في شمس أبو ظبي على جزيرة الريم، بالإضافة إلى حلبة الفورمولا 1 في جزيرة ياس وراء نجاحنا أكثر من 500 موظف متعددي التخصصات مهمتهم تقديم الخبرة والمعرفة من جميع أنحاء العالم We were established to create world-class real estate developments for the nation of Abu Dhabi, whilst providing a stable and profitable investment portfolio for all our investors. We are dedicated to achieving new standards of innovation, excellence and value in urban design and sustainable development. Our priority is the immediate and future benefit of Abu Dhabi and its residents. We developed exciting and innovative project from residential to retail, hospitality and commercial, such as the internationally recognized HQ building situated in the Al Raha Beach development, the Gate Towers in Shams Abu Dhabi on Al Reem Island, in addition to Yas Island’s F1 circuit. Behind our success there are over 500 multi-disciplinary staff providing expertise and knowledge from around the globe.

Follow our official M42 page to keep up-to-date with all of our latest updates and developments: https://bit.ly/3Q5l8Vx M42 combines cutting-edge medical technologies and research with state-of-the-art facilities to deliver world-class care. Based in Abu Dhabi, M42 leads the healthcare sector with its tech-driven approach, focusing on innovative clinical solutions to address global health challenges. With expertise in genomics and AI, we are reshaping the healthcare landscape by delivering precise, patient-centric, and preventive care solutions.

Mubadala Capital was established in 2011, and in 2017, we became one of the first sovereign wealth-affiliated alternative asset managers to manage third-party capital on behalf of institutional investors across the globe. In just over a decade, we have built a new type of investment firm, one designed to evolve alongside the shifting alternative investment landscape and meet the needs of investors of all types, including private wealth. Our ability to navigate complexity and unlock value positions us ahead of market trends, while our commitment to building enduring businesses enables long-term, sustainable returns. Learn more at www.mubadalacapital.ae

Ellipses Pharma is an international drug development company, focused exclusively on the advancement of innovative cancer treatments through the clinic. New treatments for cancer are not progressing fast enough. Ellipses is dedicated to making a difference. Headquartered in London, Ellipses is run by a world class leadership team, overseeing a rapidly growing pipeline of high quality clinical oncology opportunities. Supported by privileged partnerships with leading academic institutions, research bodies, universities, Big Pharma and extensive professional networks, Ellipses Pharma aims to be the most direct route from the research laboratory to patients for cancer treatments. Clinical trials are the route to developing more cancer treatments. All too often they have become overly complex and expensive, slowing down the progress of new discoveries and new treatments for patients. We streamline the clinical trials process that so often inhibits the progress of new potential drugs with one overarching objective - making more treatments available to patients. Ellipses provides a permanent source of capital for the development of cancer assets via a scalable business model, and is able to conduct multiple oncology clinical trials in parallel. Supported by our Scientific Affairs Group which comprises many of the worlds leading oncologists, Ellipses is taking a new, ambitious approach to significantly impact the cancer drug development market.

FAB, the UAE’s largest bank and one of the world’s largest financial institutions offers an extensive range of tailor-made solutions, and products and services, to provide a customised banking experience. Through its strategic offerings, it looks to meet the banking needs of customers across the world via its market-leading Corporate and Investment Banking and Personal Banking franchises. Headquartered in Abu Dhabi, in Khalifa Business Park, the bank’s international network spans over 19 countries, across the world, providing the global relationships, expertise and financial strength to support local, regional and international businesses seeking to do business at home and abroad. In line with its commitment to put customers first, to Grow Stronger, FAB will continually invest in people and technology to create the most customer-friendly banking experience and will support the growth ambitions of its stakeholders across the global network in which the bank operates. To empower its customers and clients to Grow Stronger, FAB is initiating a powerful movement, which goes beyond banking. The Grow Stronger movement represents the bank’s promise to support its stakeholders’ goals and growth ambitions, providing ideas, tools and expertise to help them become stronger, today and in the future. Through a strong, diversified balance sheet, leading efficiency and a solid corporate governance structure in place, FAB is set to drive growth forward. Privacy Policy https://bit.ly/3iORn8G

Home to Tech Startups from all sectors looking to disrupt industries, setup and grow their businesses from Abu Dhabi to the world. 🌍 #Hub71